ArticleFrontiers in medicine2025
A study on predicting impaired fasting glucose risk in Chinese adults based on individual characteristics.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Retrospective cohort study of body fat percentage and incident impaired fasting glucose among Chinese adults.Scientific reports · 2026Article
- Association between ZJU index and glycemic outcomes in individuals with impaired fasting glucose: a retrospective multicenter Chinese cohort study.Frontiers in endocrinology · 2026Article
- Association between the ratio of aspartate aminotransferase to alanine aminotransferase and risk of diabetes and the mediating effect of BMI: a comparative analysis in Chinese and Japanese populations.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to develop a nomogram for early detection of impaired fasting glucose (IFG), predicting the 5-year risk in Chinese adults due to its link to various diseases. Materials and methods: This retrospective cohort study included 28,875 participants without IFG at baseline, randomly divided them to a training set and a validation set. We developed four predictive models-LASSO, full, stepwise, and MFP-ultimately selecting the LASSO model for nomogram development due to its simplicity and predictive performance. Four prediction model performance was assessed through ROC analysis, calibration curves, and decision curve analysis, with external validation using Shunde Hospital ( Results: We developed a nomogram to predict the risk of IFG by incorporating parameters including age, body mass index (BMI), systolic blood pressure (SBP), fasting plasma glucose (FPG), and triglycerides (TG), which demonstrated performance with AUCs of 0.8167 and 0.8155 in the training and validation set, respectively. External validation achieved AUC 0.9665 (Shunde Hospital dataset) and 0.9171 (NHANES). Conclusions: Our nomogram provides a personalized, validated approach for assessing 5-year IFG risk in Chinese adults, offering a practical screening tool for primary healthcare and resource-constrained environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.